Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/1/26 18:49 | 7/1/26 | LXEO | Health | BioPrd | Biological Products, (No Diag | Tamayo Louis Edward | NY | O | CFO | 1 | S | -21 | 4.49 | 0 | -5 | 97 | D | |||||||||||||||
7/1/26 18:49 | 7/1/26 | LXEO | Health | BioPrd | Biological Products, (No Diag | Otero Jose Manuel | NY | O | COO | 2 | S | -28 | 4.61 | 0 | -6 | 137 | D | |||||||||||||||
7/1/26 18:48 | 7/1/26 | LXEO | Health | BioPrd | Biological Products, (No Diag | Bhalla Narinder Pal | NY | O | Chief Me | 1 | S | -99 | 4.42 | 0 | -22 | 82 | D | |||||||||||||||
7/1/26 18:47 | 7/1/26 | LXEO | Health | BioPrd | Biological Products, (No Diag | Townsend Richard Nolan | NY | DO | CEO | 2 | S | -133 | 4.55 | 0 | -29 | 378 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |